Investors considering a purchase of Harrow Inc (Symbol: HROW) stock, but tentative about paying the going market price of $35.48/share, might benefit from considering selling puts among the ...

Harrow's Q1 revenue and adjusted EBITDA missed expectations, exposing the need for improved revenue conversion and operating ...

Investors considering a purchase of Harrow Inc (Symbol: HROW) shares, but tentative about paying the going market price of $32.54/share, might benefit from considering selling puts among the ...

Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it will report its financial results for the first quarter ended March 31, ...